Bioventus Inc. (BVS) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $2.56M | +154.7% |
| 2024 | $1.01M | -86.3% |
| 2023 | $7.36M | +398.1% |
| 2022 | $1.48M | -89.1% |
| 2021 | $13.52M | -18.5% |
| 2020 | $16.58M | +607.9% |
| 2019 | $2.34M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $2.56M | +154.7% |
| 2024 | $1.01M | -86.3% |
| 2023 | $7.36M | +398.1% |
| 2022 | $1.48M | -89.1% |
| 2021 | $13.52M | -18.5% |
| 2020 | $16.58M | +607.9% |
| 2019 | $2.34M | — |